These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar

Zacks identifies Morgan Stanley and Lemonade as potential earnings-beat candidates based on positive Earnings ESP readings. Morgan Stanley holds a Zacks Rank #2 and has a +3.14% ESP, with its $3.11 most-accurate EPS estimate above the $3.01 consensus ahead of its October 14, 2026 report. Lemonade, rated #3, has a +1.12% ESP, with a -$0.59 estimate versus -$0.60 consensus ahead of November 4, 2026 earnings.

Analysis

The estimate dispersion is not, by itself, an investable signal for MS. A modest upward revision can reflect analysts catching up to already-visible market activity rather than incremental earnings power; the stock’s reaction will hinge on wealth-management net new assets, investment-banking fee conversion, trading revenues, and forward expense guidance. Over the next 30 days, MS is more exposed to rates and capital-markets beta than to a small consensus EPS beat, making a standalone pre-earnings long unattractive without evidence that buy-side expectations remain below revised sell-side numbers.

LMND is a higher-beta but less clean expression of an earnings surprise. For a loss-making insurer, investors should prioritize in-force premium growth, gross loss ratio excluding catastrophes, reserve development, and cash-burn trajectory over a narrow per-share loss outcome. A better reported loss without durable improvement in underwriting economics could compress the multiple quickly; conversely, credible evidence that AI-led acquisition costs and claims handling are lowering the combined ratio would have a 6-18 month valuation impact far larger than the quarterly print.

Contrarian view: mechanically positive revision screens are widely consumed and can raise expectations into results, particularly when the underlying revision is small. The more actionable setup is post-report: buy confirmation where guidance and operating KPIs validate the revision, rather than paying implied volatility for a binary beat that may already be priced.

Key Decisions for Investors

• MS: remain neutral into the October 14 report; upgrade to a 1-3 month long only if management raises full-year wealth-management margin or investment-banking outlook and the stock outperforms XLF on the day. Falsifier: flat-to-down revenue guidance or a meaningful expense reset despite an EPS beat.
• MS relative-value watch: if capital-markets activity is demonstrably accelerating, prefer long MS / short XLF for 1-3 months rather than outright MS, isolating franchise-specific fee and trading upside from broad bank-rate risk. Do not initiate without current valuation, short-interest, and options-implied-move data.
• LMND: avoid a pre-November 4 directional position unless quarterly disclosures show sustained loss-ratio and operating-expense leverage. A post-earnings long is warranted only if underwriting KPIs improve alongside reduced cash burn; otherwise, a beat driven by non-operating items or reserve timing is a potential short-on-strength setup.
• Set alerts for sector read-throughs from PIPR, SCHW, GS and BLK earnings before MS, and from PGR, ALL and ROOT before LMND. Revisions to fee revenue, client assets, pricing, or loss-cost trends will be more informative than the current consensus spread.